We are live on ! Find out more
LABS

Direxion Daily S&P Biotech Bear 1X Shares
LABS

Delisted

LABS was delisted on the 25th of September, 2017.

Back to rankings

2 hedge funds and large institutions have $2.19M invested in Direxion Daily S&P Biotech Bear 1X Shares in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

50% more capital invested

Capital invested by funds: $1.46M → $2.19M (+$733K)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$1.94M
2
Jane Street
Jane Street
New York
+$277K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$1.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
1
Citigroup
New York
$1.92M +$1.94M +49,900 New
Jane Street
2
Jane Street
New York
$273K +$277K +7,118 New
VF
3
Virtu Financial
New York
– -$1.46M -38,582 Closed

LABS Hedge Fund Activity: Q4 2016 in Review

2 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 1X Shares (LABS) for Q4 2016, worth a combined $2.19M — up 50% from $1.46M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new LABS positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citigroup, opening a new position worth an estimated $1.94M. The largest seller was Virtu Financial, exiting entirely with an estimated $1.46M sold.

  • 2 institutional investors held Direxion Daily S&P Biotech Bear 1X Shares (LABS) as of Q4 2016, up from 1 in Q3 2016.
  • Funds reported $2.19M of Direxion Daily S&P Biotech Bear 1X Shares stock for Q4 2016, up 50% quarter-over-quarter.
  • 2 funds opened new Direxion Daily S&P Biotech Bear 1X Shares positions in Q4 2016 and 1 closed out, a net change of +1 holder.
  • The largest Direxion Daily S&P Biotech Bear 1X Shares buyer in Q4 2016 was Citigroup, an estimated $1.94M added.
  • The largest Direxion Daily S&P Biotech Bear 1X Shares seller in Q4 2016 was Virtu Financial, an estimated $1.46M sold.

Based on aggregated 13F filings for Q4 2016.